$P

Taylor Susan J.S. sold $698K of P

Taylor Susan J.S. sold 8,543 shares of Everpure, Inc. (P) at $81.74 ($0.70M total) on 2026-07-09.

Original reporting
SEC EDGAR · Taylor Susan J.S.
Published Jul 13, 2026, 9:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 13, 2026, 9:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$P
Neutral
medium confidence
Mentioned
$P
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PNeutralLow
01

Why it matters

The disclosed sale may attract short-term attention, but it provides no new operational or financial information about Everpure.

02

Market read

Traders may monitor for follow-on insider activity, but the disclosure alone is unlikely to drive a durable repricing.

03

What to watch

The filing does not state motivations, whether other insiders sold/bought, or whether there are concurrent corporate events; traders should avoid over-weighting a single sale.

Relevance 5/10Novelty 5/10Timing: Filed on 2026-07-13 for a sale dated 2026-07-09.

Background

The article is an SEC Form 4 insider transaction disclosure for Everpure, Inc., reporting a director’s open-market sale.

Company-level read

Ticker impact

$PNeutralMedium confidence
Context

Everpure director Taylor Susan J.S. sold 8,543 shares in an open-market transaction for about $698,304.82 at $81.74/share, per Form 4.

Expected impact

Likely limited near-term impact; any reaction would be sentiment-driven and typically fades unless paired with other disclosures.

Evidence & confidence

Form 4 insider sales are common and often non-informational; the article provides transaction size, price, and that there was no pre-arranged 10b5-1 plan, which can raise attention but still lacks a fundamental catalyst.

Market effects

No sector-level implications; this is company-specific insider transaction reporting.

None indicated.

None indicated.

Counterpoint

The absence of a 10b5-1 plan does not necessarily imply negative information; directors may sell for diversification, taxes, or planned liquidity needs.

Key entities

  • Everpure, Inc.

    Company whose director insider sale is disclosed on Form 4.

  • Taylor Susan J.S.

    Director who sold 8,543 shares at $81.74/share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PHighAI 8/10

Everpure (P) Shares Rise After CFRA Upgrade and Strong Fiscal 20

Everpure Inc (NYSE: P) shares rose 3% after CFRA upgraded it from Sell to Buy, citing raised guidance for fiscal 2028. The company projects $7B-$7.3B in revenue and $1.7B-$1.9B in non-GAAP operating income, driven by demand for its all-flash storage solutions in AI data centers. Despite this, GuruFocus's GF Value™ suggests the stock is overvalued at $126.00, with an intrinsic value of $81.40.

$METAMedAI 8/10

Meta, Everpure, Akamai Technologies, Apimeds Pharmaceuticals and Costco: Why These 5 Stocks Are on Invest

Meta (META) rose 4.5% to $777.59, driven by AI strategy. Everpure (P) surged 11.15% to $121.88, reaffirming fiscal 2027 guidance. Akamai (AKAM) fell 6.78% to $110.41, then jumped 20.65% after-hours on a $11.6B AI deal. Apimeds (APUS) soared 114.85% to $4.92 on a blockchain agreement. Costco (COST) dipped 0.91% to $896.48 despite beating Q4 estimates.

$PHighAI 8/10

Everpure Stock Jumps As S&P 500 Inclusion Fuels Momentum

Everpure Inc. (NYSE: P) stock rose 12.77% after its inclusion in the S&P 500. The company's shares have climbed from the low-$90s to $121.88, with a high of $131.41. Everpure reported $3.66B in annual revenue, 70.2% gross margins, and a P/E above 380. The S&P 500 inclusion is expected to drive passive fund buying.

$PMed

Needham raises Everpure stock price target on strong FY28 outlook

Needham raised its price target for Everpure (NYSE:P) to $150 from $140, maintaining a Buy rating. The firm cited Everpure's strong fiscal 2028 outlook, with projected revenue growth of 39% to 45% and operating margins of 24% to 26%. The company also reported second-quarter fiscal 2027 revenue of $1.186 billion, up 38% year-over-year. Several analysts have revised earnings upwards, and the stock has returned 68.3% over the last six months.